Add like
Add dislike
Add to saved papers

Microarray-Based Immunoassay with Synthetic Mimotopes for the Detection of Fumonisin B1.

Mimotopes, or epitope mimics, can be applied to competitive immunoassays, for the detection of low molecular weight natural toxicants, as an alternative to toxin-conjugates. In this work, we report the development of a microarray-based immunoassay for the detection of fumonisin B1 using a novel mimotope selected by phage display technology. Fumonisin-specific antibody was used to isolate mimotopes from a 12-mer peptide library in successive selection rounds. Enrichment of antibody binding phages was observed after three panning rounds, and sequence analysis of randomly selected monoclonal phages revealed two conserved peptide sequences. Clone A2, with peptide sequence VTPNDDTFDPFR, showed the best response in enzyme-linked immunosorbent assay (ELISA) in terms of sensitivity and reproducibility and was selected for microarray development. A biotinylated synthetic derivative of this mimotope was immobilized onto epoxy-glass slides, and fumonisin B1 was detected in a competitive binding inhibition assay using the antifumonisin antibody and a labeled secondary antibody. The array showed an IC50 value of 37.1 ± 2.4 ng mL(-1) (n = 9), a detection limit of 11.1 ng mL(-1), and a dynamic range from 17.3 to 79.6 ng mL(-1). Good specificity toward fumonisin B1 and its structural analog, fumonisin B2, was observed, together with negligible cross-reactivity for other mycotoxins produced by the same fungi species. The mimotope microarray was applied to the analysis of fumonisin B1 in spiked maize and wheat samples. The method enabled quantification of the mycotoxin at the levels set by European legislation and holds promise for future adaptation to include other mycotoxins for multiplex detection.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app